Who has invested in Precirix?

INKEF Capital, Jeito Capital, Forbion, Gimv, HealthCap, Novo Holdings are named among the investors backing Precirix.

Precirix Funding: $124M Raised, Series B (2021)

Precirix funding overview

Precirix is based in Brussels, Belgium. Precirix has raised $124M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in December 2021. The round record for Precirix runs through 2021; nothing later has been disclosed. Investors on record include INKEF Capital, Jeito Capital, Forbion, Gimv, HealthCap, Novo Holdings and 3 others. 9 distinct backers are named across the disclosed rounds.

Precirix at a glance

Total raised: $124M
Latest round: Series B
Latest round date: December 2021
Headquarters: Brussels, Belgium
Notable investors: INKEF Capital, Jeito Capital, Forbion, Gimv, HealthCap, Novo Holdings, Pontifax Venture Capital, V-Bio Ventures

Frequently asked about Precirix funding

How much has Precirix raised?: Precirix has raised $124M in total disclosed funding across the rounds on record.
Who has invested in Precirix?: INKEF Capital, Jeito Capital, Forbion, Gimv, HealthCap, Novo Holdings are named among the investors backing Precirix.
What was the latest Precirix funding round?: The most recent disclosed round is a Series B, announced in December 2021.
Where is Precirix based?: Precirix is based in Brussels, Belgium.
When did Precirix last raise?: The last disclosed Precirix round closed in December 2021 at Series B.

Totals shown for Precirix aggregate every disclosed round on file. To see how that compares, browse the companies in Brussels and the investors behind them below.

Precirix Funding: $124M Raised, Series B (2021)

Precirix funding overview

Precirix at a glance

Frequently asked about Precirix funding

Companies related to Precirix (21)

Browse related funding lists (7)